BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7787143)

  • 1. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.
    Vallon V; Wead LM; Blantz RC
    J Am Soc Nephrol; 1995 Apr; 5(10):1761-7. PubMed ID: 7787143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic salt loading on kidney function in early and established diabetes mellitus in rats.
    Vallon V; Kirschenmann D; Wead LM; Lortie MJ; Satriano J; Blantz RC; Thomson SC
    J Lab Clin Med; 1997 Jul; 130(1):76-82. PubMed ID: 9242369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of reduction of nitric oxide on plasma and kidney tissue angiotensin II levels.
    Garcia GE; Brown MR; Wead LM; Braun S; Gabbai FB
    Am J Hypertens; 1997 Oct; 10(10 Pt 1):1103-8. PubMed ID: 9370380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
    Allen TJ; Waldron MJ; Casley D; Jerums G; Cooper ME
    Diabetes; 1997 Jan; 46(1):19-24. PubMed ID: 8971091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration.
    Mathis KM; Banks RO
    J Am Soc Nephrol; 1996 Jan; 7(1):105-12. PubMed ID: 8808116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin II on the renal response to amino acid in rats.
    Garcia GE; Hammond TC; Wead LM; Mendonca MM; Brown MR; Gabbai FB
    Am J Kidney Dis; 1996 Jul; 28(1):115-23. PubMed ID: 8712205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited capacity for renal vasodilatation in anesthetized diabetic rats.
    Ha H; Dunham EW
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H845-55. PubMed ID: 3661732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of calcium blocker on renal hemodynamics in diabetic spontaneously hypertensive rat.
    Kaizu K; Ling QY; Uriu K; Ikeda M; Eto S
    J Diabetes Complications; 1995; 9(4):301-3. PubMed ID: 8573752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of proximal tubules to angiotensin II changes during maturation.
    Garvin JL; Beierwaltes WH
    Hypertension; 1998 Jan; 31(1 Pt 2):415-20. PubMed ID: 9453338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of renal hemodynamics and glomerular filtration rate in chronic hypercalcemia. Role of prostaglandins, renin-angiotensin system, and calcium.
    Levi M; Ellis MA; Berl T
    J Clin Invest; 1983 Jun; 71(6):1624-32. PubMed ID: 6345587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of altered sodium balance upon renal vascular reactivity to angiotensin II and norepinephrine in the dog. Mechanism of variation in angiotensin responses.
    Oliver JA; Cannon PJ
    J Clin Invest; 1978 Mar; 61(3):610-23. PubMed ID: 641142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Mas receptor antagonist (A779) in renal hemodynamics in condition of blocked angiotensin II receptors in rats.
    Mansoori A; Oryan S; Nematbakhsh M
    Physiol Int; 2016 Mar; 103(1):13-20. PubMed ID: 27030624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs.
    Navar LG; Jirakulsomchok D; Bell PD; Thomas CE; Huang WC
    Hypertension; 1982; 4(1):58-68. PubMed ID: 6174445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
    van der Linde NA; van den Meiracker AH; Boomsma F
    J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
    Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
    Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamic effects of captopril in anesthetized sodium-restricted dogs. Relative contributions of prostaglandin stimulation and suppressed angiotensin activity.
    Carmines PK; Rosivall L; Till MF; Navar LG
    Ren Physiol; 1983; 6(6):281-7. PubMed ID: 6359304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition.
    Turkstra E; Braam B; Koomans HA
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):593-600. PubMed ID: 9781927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.